The global endoscopy ultrasound market is expected to grow at a CAGR of 5.5% during forecast period 2021 – 2027 and to reach valuation USD 1.3 bn by the end of 2027.
Endoscopy ultrasound (EUS) is a minimally invasive technique used by surgeons and physicians to diagnose and treat various conditions of the gastrointestinal tract, including gastrointestinal cancers, pancreatic conditions, and others. Increase in prevalence of gastric cancers, including upper and lower GI cancers and higher accuracy and specificity of endoscopy ultrasound techniques for the diagnosis of these conditions are some of the major factors propelling the global endoscopy ultrasound market.
The endoscopy ultrasound market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, application, procedure, technology, end-user, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises a competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis, by key players, thus presenting a thorough analysis of the overall competitive scenario in the global endoscopy ultrasound market.
The drive for endoscopy ultrasound market gathered a marked momentum in recent years from the clinical role of endoscopy in therapeutic procedures. The diagnostic capabilities have also advanced on the back of advancement in imaging modalities. Key manufacturers in the endoscopy ultrasound market have harnessed these advancements to meet the clinical demand for identifying pancreaticobiliary malignancies, and other benign pancreatic disorders.
The use of fine needle biopsies in cancer management is one of the key trend bolstering growth of the endoscopy ultrasound market. The increasing incidence of gastrointestinal cancers and the growing awareness about their morbidity in patient populations have led to unlocking new demand dynamic in developing and developed regions.
Endoscopy ultrasound methods are being used in territories separated from oncology, and interest for new endoscopy ultrasound procedures, for example, elastography and differentiate improved endoscopy ultrasound (CE-EUS) is on the ascent. This is fuelling interest for new and propelled items in the worldwide market. These elements are additionally anticipated to support the market from 2021 to 2027. The Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and different offices have set down exacting arrangements for the preparation and instruction of gifted experts performing endoscopy ultrasound methods. In any case, absence of talented experts in the part and absence of preparing and training programs in rising nations are anticipated to be major limiting components of the worldwide endoscopy ultrasound market in the coming years.
Growing Awareness of Morbidity of Tumors Spurs Demand in All Clinical Settings
The demand for technologies for optimal targeting and diagnosis in tumors has spurred demand for new endoscopy technologies in the endoscopy ultrasound market. Continuous strides have been made by medical device makers to meet the objectives of higher precision in the characterization and staging. These are boosting the application of the modalities in both therapeutic as well as diagnostic applications.
In recent years, the endoscopy ultrasound market has gained sizable revenues on account of the uptake in EUS-FNA procedures. In addition, elastography procedures have also risen in popularity. The demand for endoscopy in such procedures is underpinned by the growing popularity of minimally invasive procedures.
Some of the well-entrenched industry stakeholders in the endoscopy ultrasound market include names such as ACE Medical Devices, Olympus Corporation, Medtronic PLC, CONMED Corporation, Medi-Globe GmbH, and Boston Scientific Corporation.
Continuous Microscopy Advancements Drive Endoscopy Ultrasound Market
Massive microscopy advancements have been key characteristic of new launches in the global endoscopy ultrasound market, especially of lucrative regional markets. One of these is North America which is expected to hold the major share in the endoscopy ultrasound market. The trend in uptake of various endoscopy ultrasound modalities is in account of the clinical significance of endoscopy in the treatment of diseases related to gastroenterology, oncology, and pulmonology. Moreover, the regional market is thronged by the presence of several top players over the past few years.
Asia Pacific Holds Vast Latent Opportunities
On the other side of the spectrum are the regions that will be key to rise in revenues. One of these is Asia Pacific. The regional market is expected to rise at promising pace through 2027.
Rising geriatric population has been spurring the demand for technologies requirement for advancing the therapeutic and diagnostic capabilities of devices used in radiology and in hospital setting. This has also spurred demand for better endoscopy ultrasound in improving characterization of lesions for the management of a wide range of chronic conditions. Countries such as India have seen the rise of endoscopy ultrasound in the management of cancer, including its characterization and staging among the regional population. This has expanded the horizon of the endoscopy ultrasound market.
North America represented a prevailing portion of the worldwide endoscopy ultrasound market in 2020. More popularity for cutting edge indicative methods in oncology, accessibility of new and propelled items in the U.S., and increment in rate of gastric tumors were a portion of the central point prompting the expanded appropriation of endoscopy ultrasound procedures in the market in North America 2020. The appropriation of EUS methods is consistently picking up pace in Asia Pacific, inferable from the usage of legitimate preparing and instructive projects for specialists and ascend in inclination of social insurance suppliers for negligibly intrusive EUS procedures in the analysis and treatment of gastrointestinal conditions.
The endoscopy ultrasound market is segmented based on:
Product
Application
Technology
End Use
Region
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Endoscopy Ultrasound Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Endoscopy Ultrasound Market Analysis and Forecasts, 2016–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Price Comparison Analysis (2017)
5.1.1. By Product
5.1.2. By Region
5.2. Key Potential Customers
5.3. Key Vendor and Distributor Analysis
5.4. Key Industry Developments
5.5. Key Product/Brand Analysis
5.6. Technological Advancement in Endoscopy Ultrasound (EUS) Market
5.7. Diagnostic and Therapeutic Roles of Endoscopic Ultrasound
6. Global Endoscopy Ultrasound Market Analysis and Forecasts, by Product
6.1. Introduction and Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2016–2027
6.3.1. Endoscope
6.3.2. Ultrasound Probe
6.3.3. Ultrasonic Processor
6.3.4. Imaging Systems
6.3.5. Needles
6.3.6. Accessories
6.4. Market Attractiveness, by Product
7. Global Endoscopy Ultrasound Market Analysis and Forecasts, by End-user
7.1. Introduction and Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2016–2027
7.3.1. Hospitals
7.3.2. Ambulatory Surgery Centers
7.3.3. Specialty Clinics
7.3.4. Diagnostic Centers
7.4. Market Attractiveness, by End-user
8. Global Endoscopy Ultrasound Market Analysis and Forecasts, by Technology
8.1. Introduction and Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Technology, 2016–2027
8.3.1. Radial Scanning
8.3.2. Linear Scanning
8.4. Market Attractiveness, by Technology
9. Global Endoscopy Ultrasound Market Analysis and Forecasts, by Application
9.1. Introduction and Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Application, 2016–2027
9.3.1. Oncology
9.3.1.1. Upper GI Oncology
9.3.1.2. Lower GI Oncology
9.3.2. Pancreatic Conditions
9.3.3. Others
9.4. Market Attractiveness, by Application
10. Global Endoscopy Ultrasound Market Analysis and Forecasts, by Procedure
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by Procedure, 2016–2027
10.3.1. Upper EUS
10.3.2. Lower EUS
10.3.3. EUS Guided Fine-needle Aspiration
10.3.4. Others
10.4. Market Attractiveness, by Procedure
11. Global Endoscopy Ultrasound Market Analysis and Forecasts, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region
12. North America Endoscopy Ultrasound Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2016–2027
12.2.1. Endoscope
12.2.2. Ultrasound Probe
12.2.3. Ultrasonic Processor
12.2.4. Imaging Systems
12.2.5. Needles
12.2.6. Accessories
12.3. Market Value Forecast, by End-user, 2016–2027
12.3.1. Hospitals
12.3.2. Ambulatory Surgery Centers
12.3.3. Specialty Clinics
12.3.4. Diagnostic Centers
12.4. Market Value Forecast, by Technology, 2016–2027
12.4.1. Radial Scanning
12.4.2. Linear Scanning
12.5. Market Value Forecast, by Application, 2016–2027
12.5.1. Oncology
12.5.1.1. Upper GI Oncology
12.5.1.2. Lower GI Oncology
12.5.2. Pancreatic Conditions
12.5.3. Others
12.6. Market Value Forecast, by Procedure, 2016–2027
12.6.1. Upper EUS
12.6.2. Lower EUS
12.6.3. EUS Guided Fine-needle Aspiration
12.6.4. Others
12.7. Market Value Forecast, by Country, 2016–2027
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By End-user
12.8.3. By Technology
12.8.4. By Application
12.8.5. By Procedure
12.8.6. By Country
13. Europe Endoscopy Ultrasound Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2016–2027
13.2.1. Endoscope
13.2.2. Ultrasound Probe
13.2.3. Ultrasonic Processor
13.2.4. Imaging Systems
13.2.5. Needles
13.2.6. Accessories
13.3. Market Value Forecast, by End-user, 2016–2027
13.3.1. Hospitals
13.3.2. Ambulatory Surgery Centers
13.3.3. Specialty Clinics
13.3.4. Diagnostic Centers
13.4. Market Value Forecast, by Technology, 2016–2027
13.4.1. Radial Scanning
13.4.2. Linear Scanning
13.5. Market Value Forecast, by Application, 2016–2027
13.5.1. Oncology
13.5.1.1. Upper GI Oncology
13.5.1.2. Lower GI Oncology
13.5.2. Pancreatic Conditions
13.5.3. Others
13.6. Market Value Forecast, by Procedure, 2016–2027
13.6.1. Upper EUS
13.6.2. Lower EUS
13.6.3. EUS Guided Fine-needle Aspiration
13.6.4. Others
13.7. Market Value Forecast, by Country/Sub-region, 2016–2027
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By End-user
13.8.3. By Technology
13.8.4. By Application
13.8.5. By Procedure
13.8.6. By Country/Sub-region
14. Asia Pacific Endoscopy Ultrasound Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2016–2027
14.2.1. Endoscope
14.2.2. Ultrasound Probe
14.2.3. Ultrasonic Processor
14.2.4. Imaging Systems
14.2.5. Needles
14.2.6. Accessories
14.3. Market Value Forecast, by End-user, 2016–2027
14.3.1. Hospitals
14.3.2. Ambulatory Surgery Centers
14.3.3. Specialty Clinics
14.3.4. Diagnostic Centers
14.4. Market Value Forecast, by Technology, 2016–2027
14.4.1. Radial Scanning
14.4.2. Linear Scanning
14.5. Market Value Forecast, by Application, 2016–2027
14.5.1. Oncology
14.5.1.1. Upper GI Oncology
14.5.1.2. Lower GI Oncology
14.5.2. Pancreatic Conditions
14.5.3. Others
14.6. Market Value Forecast, by Procedure, 2016–2027
14.6.1. Upper EUS
14.6.2. Lower EUS
14.6.3. EUS Guided Fine-needle Aspiration
14.6.4. Others
14.7. Market Value Forecast, by Country/ Sub-Region, 2016–2027
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Product
14.8.2. By End-user
14.8.3. By Technology
14.8.4. By Application
14.8.5. By Procedure
14.8.6. By Country/Sub-region
15. Latin America Endoscopy Ultrasound Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2016–2027
15.2.1. Endoscope
15.2.2. Ultrasound Probe
15.2.3. Ultrasonic Processor
15.2.4. Imaging Systems
15.2.5. Needles
15.2.6. Accessories
15.3. Market Value Forecast, by End-user, 2016–2027
15.3.1. Hospitals
15.3.2. Ambulatory Surgery Centers
15.3.3. Specialty Clinics
15.3.4. Diagnostic Centers
15.4. Market Value Forecast, by Technology, 2016–2027
15.4.1. Radial Scanning
15.4.2. Linear Scanning
15.5. Market Value Forecast, by Application, 2016–2027
15.5.1. Oncology
15.5.1.1. Upper GI Oncology
15.5.1.2. Lower GI Oncology
15.5.2. Pancreatic Conditions
15.5.3. Others
15.6. Market Value Forecast, by Procedure, 2016–2027
15.6.1. Upper EUS
15.6.2. Lower EUS
15.6.3. EUS Guided Fine-needle Aspiration
15.6.4. Others
15.7. Market Value Forecast, by Country/Sub-region, 2016–2027
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Product
15.8.2. By End-user
15.8.3. By Technology
15.8.4. By Application
15.8.5. By Procedure
15.8.6. By Country/Sub-region
16. Middle East & Africa Endoscopy Ultrasound Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product, 2016–2027
16.2.1. Endoscope
16.2.2. Ultrasound Probe
16.2.3. Ultrasonic Processor
16.2.4. Imaging Systems
16.2.5. Needles
16.2.6. Accessories
16.3. Market Value Forecast, by End-user, 2016–2027
16.3.1. Hospitals
16.3.2. Ambulatory Surgery Centers
16.3.3. Specialty Clinics
16.3.4. Diagnostic Centers
16.4. Market Value Forecast, by Technology, 2016–2027
16.4.1. Radial Scanning
16.4.2. Linear Scanning
16.5. Market Value Forecast, by Application, 2016–2027
16.5.1. Oncology
16.5.1.1. Upper GI Oncology
16.5.1.2. Lower GI Oncology
16.5.2. Pancreatic Conditions
16.5.3. Others
16.6. Market Value Forecast, by Procedure, 2016–2027
16.6.1. Upper EUS
16.6.2. Lower EUS
16.6.3. EUS Guided Fine-needle Aspiration
16.6.4. Others
16.7. Market Value Forecast, by Country/Sub-region, 2016–2027
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Product
16.8.2. By End-user
16.8.3. By Technology
16.8.4. By Application
16.8.5. By Procedure
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis by Company (2017)
17.3. Competitive Business Strategies
17.4. Company Profiles
17.4.1. Olympus Corporation
17.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.4.1.2. Financial Overview
17.4.1.3. Product Portfolio
17.4.1.4. SWOT Analysis
17.4.1.5. Strategic Overview
17.4.2. PENTAX Medical
17.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.4.2.2. Financial Overview
17.4.2.3. Product Portfolio
17.4.2.4. SWOT Analysis
17.4.2.5. Strategic Overview
17.4.3. FUJIFILM Corporation
17.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.4.3.2. Financial Overview
17.4.3.3. Product Portfolio
17.4.3.4. SWOT Analysis
17.4.3.5. Strategic Overview
17.4.4. Cook
17.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.4.4.2. Product Portfolio
17.4.4.3. SWOT Analysis
17.4.4.4. Strategic Overview
17.4.5. Boston Scientific Corporation
17.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.4.5.2. Financial Overview
17.4.5.3. Product Portfolio
17.4.5.4. SWOT Analysis
17.4.5.5. Strategic Overview
17.4.6. Medtronic
17.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.4.6.2. Financial Overview
17.4.6.3. Product Portfolio
17.4.6.4. SWOT Analysis
17.4.6.5. Strategic Overview
17.4.7. Esaote SpA
17.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.4.7.2. Product Portfolio
17.4.7.3. SWOT Analysis
17.4.7.4. Strategic Overview
17.4.8. Medi-Globe GmbH
17.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.4.8.2. Product Portfolio
17.4.8.3. SWOT Analysis
17.4.8.4. Strategic Overview
17.4.9. CONMED Corporation
17.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.4.9.2. Financial Overview
17.4.9.3. Product Portfolio
17.4.9.4. SWOT Analysis
17.4.9.5. Strategic Overview